BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
58 results:

  • 1. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features.
    Wang T; Guo K; Yang S; Zhang D; Cui H; Yin J; Yuan S; Wang Y; Qi Y; Wu W
    Aging (Albany NY); 2024 Jan; 16(2):1440-1462. PubMed ID: 38226966
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders.
    Poggioli R; Hirani K; Jogani VG; Ricordi C
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7380-7400. PubMed ID: 37606147
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Case of Hepatocellular Carcinoma with Erythrocytosis].
    Mitsuhashi N; Sai G; Shimizu Y; Sakai N; Suzuki D; Kuboki S; Furukawa K; Ohtsuka M
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1771-1773. PubMed ID: 36732994
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates.
    Guo C; Tang Y; Yang Z; Li G; Zhang Y
    Front Immunol; 2022; 13():958161. PubMed ID: 36032071
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.
    Wang T; Dai L; Shen S; Yang Y; Yang M; Yang X; Qiu Y; Wang W
    Front Immunol; 2022; 13():843408. PubMed ID: 35693827
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma.
    He Q; Yang J; Jin Y
    Front Immunol; 2022; 13():869993. PubMed ID: 35493518
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling.
    Li Z; Kwon SM; Li D; Li L; Peng X; Zhang J; Sueyoshi T; Raufman JP; Negishi M; Wang XW; Wang H
    J Biol Chem; 2022 May; 298(5):101885. PubMed ID: 35367211
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
    Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma.
    Wei X; Zhao L; Ren R; Ji F; Xue S; Zhang J; Liu Z; Ma Z; Wang XW; Wong L; Liu N; Shi J; Guo X; Roessler S; Zheng X; Ji J
    Hepatology; 2021 Apr; 73(4):1381-1398. PubMed ID: 32609900
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.
    Liu X; Xu D; Liu Z; Li Y; Zhang C; Gong Y; Jiang Y; Xing B
    Clin Transl Oncol; 2020 Oct; 22(10):1730-1740. PubMed ID: 32052380
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.
    Zhao CC; Yu WW; Qi YJ; Xu LF; Wang ZR; Qiang YW; Ma F; Ma XL
    Anticancer Drugs; 2020 Mar; 31(3):223-230. PubMed ID: 31789624
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ΗΙF1α, EGR1 and SP1 co-regulate the erythropoietin receptor expression under hypoxia: an essential role in the growth of non-small cell lung cancer cells.
    Su T; Liu P; Ti X; Wu S; Xue X; Wang Z; Dioum E; Zhang Q
    Cell Commun Signal; 2019 Nov; 17(1):152. PubMed ID: 31752873
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
    Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
    Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.
    Diaz-Beveridge R; Bruixola G; Lorente D; Caballero J; Rodrigo E; Segura Á; Akhoundova D; Giménez A; Aparicio J
    Clin Transl Oncol; 2018 Mar; 20(3):322-329. PubMed ID: 28801777
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
    Ke S; Chen S; Dong Z; Hong CS; Zhang Q; Tang L; Yang P; Zhai J; Yan H; Shen F; Zhuang Z; Wen W; Wang H
    Hepatology; 2017 Jan; 65(1):134-151. PubMed ID: 27774607
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
    Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
    Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
    Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
    Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. timp-1 expression in human colorectal cancer is associated with SMAD3 gene expression levels: a pilot study.
    Ionescu C; Braicu C; Chiorean R; Cojocneanu Petric R; Neagoe E; Pop L; Chira S; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):413-8. PubMed ID: 25532000
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.